Corporate ActionJul 8, 2026, 04:33 PM
OneMedNet Registers 11.68M Shares for Resale by Selling Stockholders
AI Summary
OneMedNet Corporation filed an Amendment No. 1 to its S-1 registration statement, registering up to 11,680,535 shares of Common Stock for resale by various selling stockholders. This includes 8,500,000 shares potentially issued under a Standby Equity Purchase Agreement with Yorkville, and 3,180,535 shares previously issued to directors Dr. Thomas Kosasa and Dr. Jeffrey Yu through investments and compensation conversions. The company will not receive any proceeds from the sale of these registered shares, which could lead to significant dilution for existing shareholders.
Key Highlights
- Registration of up to 11,680,535 shares of Common Stock for resale by selling stockholders.
- Includes 8,500,000 shares issuable under a Standby Equity Purchase Agreement (SEPA) with Yorkville.
- Includes 1,885,078 shares issued to Dr. Thomas Kosasa for $1.6 million in investments.
- Includes 1,295,457 shares issued to Dr. Jeffrey Yu for $850,000 in investments and compensation.
- OneMedNet will not receive any proceeds from the resale of these shares.
- 56,952,652 shares of Common Stock outstanding as of June 30, 2026.
- Common Stock closing price was $0.711 on Nasdaq on June 30, 2026.
Price Impact
More from ONMD